MRC Holland × GeneMind: digitalMLPA™ Validated on FASTASeq 300 and SURFSeq 5000
We are pleased to share the results of our collaboration with GeneMind, demonstrating the compatibility of digitalMLPA™ with GeneMind's FASTASeq 300 and SURFSeq 5000 sequencing platforms.
The validation study showed that both platforms deliver performance comparable to the NextSeq™ 1000 reference platform, with high-quality sequencing metrics and consistent digitalMLPA results across runs and instruments.
Highlights：
-
Balanced read distribution & high barcode purity
-
High concordance of normalised probe signals across runs and platforms
-
Strong repeatability, reproducibility
-
Consistent detection of CNVs, methylation status and targeted SNVs
With the addition of FASTASeq 300 and SURFSeq 5000 to our validated instruments, laboratories can now perform digitalMLPA on an even broader range of sequencing platforms, while maintaining the robust and reliable results expected from the technology.
We are very grateful to the GeneMind team for this successful collaboration! Click on the button below to read the application note in full.